On March 31, 2026, China's National Medical Products Administration (NMPA) released the draft Announcement on Matters Concerning Cosmetics Registration and Notification for public consultation. ¹ This draft represents a concrete step toward implementing the Opinions on Deepening the Reform of Cosmetic Administration and Promoting the High-Quality Development of the Industry, issued in November 2025.

The draft introduces significant measures to optimize the registration and notification process, including exemptions for animal testing and certificate of free sale (CFS) requirements, and provisions for data sharing among similar products. If fully implemented, these measures are expected to substantially reduce both the human resource and financial burdens faced by cosmetic manufacturers and brand owners.